Literature DB >> 26858361

Rapamycin Blocks Induction of the Thermogenic Program in White Adipose Tissue.

Cassie M Tran1, Sarmistha Mukherjee1, Lan Ye2, David W Frederick1, Megan Kissig3, James G Davis1, Dudley W Lamming4, Patrick Seale3, Joseph A Baur5.   

Abstract

Rapamycin extends life span in mice, yet paradoxically causes lipid dysregulation and glucose intolerance through mechanisms that remain incompletely understood. Whole-body energy balance can be influenced by beige/brite adipocytes, which are inducible by cold and other stimuli via β-adrenergic signaling in white adipose depots. Induction of beige adipocytes is considered a promising strategy to combat obesity because of their ability to metabolize glucose and lipids, dissipating the resulting energy as heat through uncoupling protein 1. Here, we report that rapamycin blocks the ability of β-adrenergic signaling to induce beige adipocytes and expression of thermogenic genes in white adipose depots. Rapamycin enhanced transcriptional negative feedback on the β3-adrenergic receptor. However, thermogenic gene expression remained impaired even when the receptor was bypassed with a cell-permeable cAMP analog, revealing the existence of a second inhibitory mechanism. Accordingly, rapamycin-treated mice are cold intolerant, failing to maintain body temperature and weight when shifted to 4°C. Adipocyte-specific deletion of the mTORC1 subunit Raptor recapitulated the block in β-adrenergic signaling. Our findings demonstrate a positive role for mTORC1 in the recruitment of beige adipocytes and suggest that inhibition of β-adrenergic signaling by rapamycin may contribute to its physiological effects.
© 2016 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26858361      PMCID: PMC4806661          DOI: 10.2337/db15-0502

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

1.  mTORC1 inhibition via rapamycin promotes triacylglycerol lipolysis and release of free fatty acids in 3T3-L1 adipocytes.

Authors:  Ghada A Soliman; Hugo A Acosta-Jaquez; Diane C Fingar
Journal:  Lipids       Date:  2010-11-02       Impact factor: 1.880

2.  Transcriptional control of adipose lipid handling by IRF4.

Authors:  Jun Eguchi; Xun Wang; Songtao Yu; Erin E Kershaw; Patricia C Chiu; Joanne Dushay; Jennifer L Estall; Ulf Klein; Eleftheria Maratos-Flier; Evan D Rosen
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

Review 3.  Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3).

Authors:  E Degerman; P Belfrage; V C Manganiello
Journal:  J Biol Chem       Date:  1997-03-14       Impact factor: 5.157

4.  Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

Authors:  Yifu Qiu; Khoa D Nguyen; Justin I Odegaard; Xiaojin Cui; Xiaoyu Tian; Richard M Locksley; Richard D Palmiter; Ajay Chawla
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis.

Authors:  Rajesh R Rao; Jonathan Z Long; James P White; Katrin J Svensson; Jesse Lou; Isha Lokurkar; Mark P Jedrychowski; Jorge L Ruas; Christiane D Wrann; James C Lo; Donny M Camera; Jenn Lachey; Steven Gygi; Jasbir Seehra; John A Hawley; Bruce M Spiegelman
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

6.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

7.  Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients.

Authors:  Joel D Morrisett; Ghada Abdel-Fattah; Ron Hoogeveen; Eddie Mitchell; Christie M Ballantyne; Henry J Pownall; Antone R Opekun; Jonathon S Jaffe; Suzanne Oppermann; Barry D Kahan
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

8.  Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Authors:  Vanessa P Houde; Sophie Brûlé; William T Festuccia; Pierre-Gilles Blanchard; Kerstin Bellmann; Yves Deshaies; André Marette
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

9.  Duration of rapamycin treatment has differential effects on metabolism in mice.

Authors:  Yimin Fang; Reyhan Westbrook; Cristal Hill; Ravneet K Boparai; Oge Arum; Adam Spong; Feiya Wang; Martin A Javors; Jie Chen; Liou Y Sun; Andrzej Bartke
Journal:  Cell Metab       Date:  2013-03-05       Impact factor: 27.287

Review 10.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

View more
  38 in total

Review 1.  Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue.

Authors:  Ling Yeong Chia; Bronwyn A Evans; Saori Mukaida; Tore Bengtsson; Dana S Hutchinson; Masaaki Sato
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

2.  Adipose tissue browning: mTOR branches out.

Authors:  Shogo Wada; Zoltan Arany
Journal:  Cell Cycle       Date:  2017-01-31       Impact factor: 4.534

3.  Autophagy in Adipose Tissue Physiology and Pathophysiology.

Authors:  Maroua Ferhat; Katsuhiko Funai; Sihem Boudina
Journal:  Antioxid Redox Signal       Date:  2018-11-01       Impact factor: 8.401

Review 4.  The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging.

Authors:  Brian K Kennedy; Dudley W Lamming
Journal:  Cell Metab       Date:  2016-06-14       Impact factor: 27.287

Review 5.  Brown and Beige Adipose Tissues in Health and Disease.

Authors:  Liangyou Rui
Journal:  Compr Physiol       Date:  2017-09-12       Impact factor: 9.090

6.  Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.

Authors:  Dianxin Liu; Marica Bordicchia; Chaoying Zhang; Huafeng Fang; Wan Wei; Jian-Liang Li; Adilson Guilherme; Kalyani Guntur; Michael P Czech; Sheila Collins
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

Review 7.  Taming the Flames: Targeting White Adipose Tissue Browning in Hypermetabolic Conditions.

Authors:  Abdikarim Abdullahi; Marc G Jeschke
Journal:  Endocr Rev       Date:  2017-12-01       Impact factor: 19.871

Review 8.  Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island.

Authors:  Sebastian I Arriola Apelo; Dudley W Lamming
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-05-21       Impact factor: 6.053

9.  Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice.

Authors:  Sebastian I Arriola Apelo; Cassidy P Pumper; Emma L Baar; Nicole E Cummings; Dudley W Lamming
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-18       Impact factor: 6.053

10.  Adipocyte-specific DKO of Lkb1 and mTOR protects mice against HFD-induced obesity, but results in insulin resistance.

Authors:  Yan Xiong; Ziye Xu; Yizhen Wang; Shihuan Kuang; Tizhong Shan
Journal:  J Lipid Res       Date:  2018-04-10       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.